Tag: Zelira Therapeutics

StaffFebruary 15, 2023
daily-hit.jpg

5min00
The Daily Hit is a recap of the top financial news stories for February 15, 2023. On the Site Twitter Eases up on Cannabis Marketing Cannabis companies will be able to market their brands and products on Twitter in the U.S., reversing long-standing rules on whether marijuana should be advertised on the platform in the […]

StaffDecember 17, 2020
0-5-1280x389.jpeg

3min00
Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a leader in cannabis research and the development of clinically validated cannabis medicines, just announced its newest licensing agreement for its HOPE™ line of products, Zelira’s top-selling treatment developed for autism patients. Under the agreement with Alternative Solutions, a licensed grower, manufacturer and distributor of medical cannabis products in the […]

StaffDecember 2, 2020
shutterstock_1431673145-1280x853.jpg

4min00
SprinJene and its partner Zelira Therapeutics (ASX: ZLD, OTCQB: ZLDAF) today officially launch their new CBD oral care line. In September, we reported on their partnership announcement and the future launch of their new hemp-derived CBD oral care line. The companies said their product would be available by Q4 of 2020. In a press release […]

StaffOctober 30, 2020
shutterstock_1012237351-1280x853.jpg

3min00
Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF) just announced that its proprietary cannabinoid medicines, HOPE 1™ and HOPE 2™are now available by prescription to patients in Australia. The HOPE™ forumations, developed by Zelira and noted autism advocate Erica Daniels, first launched in 2019 in Pennsylvania and this fall in Louisiana.  “We have had great success […]

StaffSeptember 11, 2020
SprinJene-CBD-Toothpaste-Photo.jpg

3min00
Zelira Therapeutics (ASX: ZLD, OTCQB: ZLDAF) announced it has entered into a partnership agreement with New Jersey based oral care company SprinJene to launch hemp-derived CBD dental products. SprinJene says it will bring its CBD toothpaste to market by the end of Q4for  distribution across retail and other channels across the US. This will be the first […]

Debra BorchardtApril 9, 2020
lab2.jpg

4min00
Zelira Therapeutics Ltd (OTCQB: ZLDAF) has received the final report for its ZTL-101 medicinal cannabis trial for insomnia. Its findings represent a world-first clinical validation demonstrating that ZTL-101 cannabis treatment is safe and effective for chronic insomnia. Dr. Oludare Odumosu, Managing Director Zelira USA said, “This trial has yielded a comprehensive data-pack that supports our […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.